These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 8338087)
21. Early postoperative complications are not increased in patients with Crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Colombel JF; Loftus EV; Tremaine WJ; Pemberton JH; Wolff BG; Young-Fadok T; Harmsen WS; Schleck CD; Sandborn WJ Am J Gastroenterol; 2004 May; 99(5):878-83. PubMed ID: 15128354 [TBL] [Abstract][Full Text] [Related]
22. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease. Myrelid P; Svärm S; Andersson P; Almer S; Bodemar G; Olaison G Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204 [TBL] [Abstract][Full Text] [Related]
23. Clinical aspects of Crohn's disease of the upper gastrointestinal tract: a comparison with distal Crohn's disease. Wagtmans MJ; Verspaget HW; Lamers CB; van Hogezand RA Am J Gastroenterol; 1997 Sep; 92(9):1467-71. PubMed ID: 9317064 [TBL] [Abstract][Full Text] [Related]
24. Ornidazole in the treatment of active Crohn's disease: short-term results. Triantafillidis JK; Nicolakis D; Emmanoullidis A; Antoniou A; Papatheodorou K; Cheracakis P Ital J Gastroenterol; 1996 Jan; 28(1):10-4. PubMed ID: 8743067 [TBL] [Abstract][Full Text] [Related]
25. 6-Thioguanine therapy in Crohn's disease--observational data in Swedish patients. Almer SH; Hjortswang H; Hindorf U Dig Liver Dis; 2009 Mar; 41(3):194-200. PubMed ID: 18799369 [TBL] [Abstract][Full Text] [Related]
26. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine. Egan LJ; Sandborn WJ; Tremaine WJ Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654 [TBL] [Abstract][Full Text] [Related]
27. In favour of prophylactic treatment for post-operative recurrence in Crohn's disease. Caprilli R; Taddei G; Viscido A Ital J Gastroenterol Hepatol; 1998 Apr; 30(2):219-25. PubMed ID: 9675663 [TBL] [Abstract][Full Text] [Related]
28. Malignant neoplasms subsequent to treatment of inflammatory bowel disease with 6-mercaptopurine. Korelitz BI; Mirsky FJ; Fleisher MR; Warman JI; Wisch N; Gleim GW Am J Gastroenterol; 1999 Nov; 94(11):3248-53. PubMed ID: 10566724 [TBL] [Abstract][Full Text] [Related]
29. Acute lower gastrointestinal bleeding in Crohn's disease: characteristics of a unique series of 34 patients. Belgian IBD Research Group. Belaiche J; Louis E; D'Haens G; Cabooter M; Naegels S; De Vos M; Fontaine F; Schurmans P; Baert F; De Reuck M; Fiasse R; Holvoet J; Schmit A; Van Outryve M Am J Gastroenterol; 1999 Aug; 94(8):2177-81. PubMed ID: 10445546 [TBL] [Abstract][Full Text] [Related]
30. Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Farrell RJ; Shah SA; Lodhavia PJ; Alsahli M; Falchuk KR; Michetti P; Peppercorn MA Am J Gastroenterol; 2000 Dec; 95(12):3490-7. PubMed ID: 11151882 [TBL] [Abstract][Full Text] [Related]
31. Basic fibroblast growth factor as a response parameter to infliximab in fistulizing Crohn's disease. Gao Q; Hogezand RA; Lamers CB; Verspaget HW Aliment Pharmacol Ther; 2004 Sep; 20(5):585-92. PubMed ID: 15339330 [TBL] [Abstract][Full Text] [Related]
32. Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study. Asteria CR; Ficari F; Bagnoli S; Milla M; Tonelli F Scand J Gastroenterol; 2006 Sep; 41(9):1064-72. PubMed ID: 16938720 [TBL] [Abstract][Full Text] [Related]
33. Preliminary report on the use of oral tacrolimus (FK506) in the treatment of complicated proximal small bowel and fistulizing Crohn's disease. Sandborn WJ Am J Gastroenterol; 1997 May; 92(5):876-9. PubMed ID: 9149205 [TBL] [Abstract][Full Text] [Related]
34. Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Hanauer SB; Smith MB Am J Gastroenterol; 1993 May; 88(5):646-9. PubMed ID: 8480725 [TBL] [Abstract][Full Text] [Related]
35. The ten-year single-center experience with 6-mercaptopurine in the treatment of inflammatory bowel disease. Glazier KD; Palance AL; Griffel LH; Das KM J Clin Gastroenterol; 2005 Jan; 39(1):21-6. PubMed ID: 15599205 [TBL] [Abstract][Full Text] [Related]
36. Infliximab heals intestinal inflammatory lesions and restores growth in children with Crohn's disease. Borrelli O; Bascietto C; Viola F; Bueno de Mesquita M; Barbato M; Mancini V; Bosco S; Cucchiara S Dig Liver Dis; 2004 May; 36(5):342-7. PubMed ID: 15191204 [TBL] [Abstract][Full Text] [Related]
37. [Treatment of Crohn's disease with anti-TNF alpha antibodies (infliximab): results of a multicentric and retrospective study]. Doubremelle M; Bourreille A; Zerbib F; Heresbach D; Metman EH; Beau P; Gournay J; Galmiche JP Gastroenterol Clin Biol; 2002 Nov; 26(11):973-9. PubMed ID: 12483127 [TBL] [Abstract][Full Text] [Related]
38. Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report. van der Hagen SJ; Baeten CG; Soeters PB; Russel MG; Beets-Tan RG; van Gemert WG Dis Colon Rectum; 2005 Apr; 48(4):758-67. PubMed ID: 15750797 [TBL] [Abstract][Full Text] [Related]
39. Endorectal advancement flap: are there predictors of failure? Mizrahi N; Wexner SD; Zmora O; Da Silva G; Efron J; Weiss EG; Vernava AM; Nogueras JJ Dis Colon Rectum; 2002 Dec; 45(12):1616-21. PubMed ID: 12473884 [TBL] [Abstract][Full Text] [Related]
40. First experience with intracytoplasmic sperm injection for extreme oligozoospermia associated with Crohn's disease and 6-mercaptopurine chemotherapy. Sills ES; Tucker MJ Asian J Androl; 2003 Mar; 5(1):76-8. PubMed ID: 12647009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]